Skip to main content
Year archive

MESOBLAST LTD — 2011 filings

All 60 regulatory filings released by MESOBLAST LTD (MESO) in 2011, sourced directly from the official regulator.

60 Filings
2011 Period
2011 filings (60)
Filing Released Lang
FORM 604 NOTICE OF CHANGE OF INTERESTS OF SUB HOLDER 6 pages 73.6KB
Regulatory Filings
2011-12-08 English
Chairman`s Address and CEO`s Presentation to Shareholders 24 pages 934.3KB
Regulatory Filings
2011-11-23 English
Corporate Strategy Key to Mesoblast`s Success 3 pages 165.6KB
Regulatory Filings
2011-11-23 English
Results of Meeting 2 pages 140.0KB
Regulatory Filings
2011-11-23 English
Positive Outcome From FDA Meeting For Diabetes Program 2 pages 224.4KB
Regulatory Filings
2011-11-21 English
Positive Heart Failure Trial Results Presented to AHA 3 pages 244.6KB
Regulatory Filings
2011-11-14 English
Presentation to the American Heart Association 24 pages 5.6MB
Regulatory Filings
2011-11-14 English
Positive Results Using Adult Stem Cells for Type 2 Diabetes 26 pages 908.8KB
Regulatory Filings
2011-11-09 English
Appendix 4C - quarterly 5 pages 142.7KB
Regulatory Filings
2011-10-30 English
Response to ASX Price Query Letter 5 pages 190.6KB
Regulatory Filings
2011-10-27 English
Clearance for First Phase 2 Clinical Trial for Eye Diseases 3 pages 242.7KB
Regulatory Filings
2011-10-23 English
Notice of Annual General Meeting/Proxy Form 8 pages 661.6KB
Regulatory Filings
2011-10-23 English
Annual Report to shareholders 96 pages 2.5MB
Regulatory Filings
2011-10-23 English
Licensing Executives Society Deals of Distinction Award 2 pages 212.5KB
Regulatory Filings
2011-10-19 English
MSB and Lonza form strategic global manufacturing alliance 2 pages 41.9KB
Regulatory Filings
2011-09-26 English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 6 pages 75.9KB
Regulatory Filings
2011-09-14 English
First European Trial for Heart Attack Treatment Cleared 2 pages 244.9KB
Regulatory Filings
2011-09-04 English
Full Year Audited Statutory Accounts 79 pages 626.3KB
Regulatory Filings
2011-08-30 English
Preliminary Final Report 26 pages 609.9KB
Regulatory Filings
2011-08-23 English
Mesoblast Management Presentation 12 pages 604.0KB
Regulatory Filings
2011-08-23 English
Mesoblast in Position of Considerable Strength 1 pa
Regulatory Filings
2011-08-23 English
First Minimally Invasive Procedure for Lumbar Disc Repair 2 pages 212.7KB
Regulatory Filings
2011-08-21 English
Heart Failure Trial Selected for AHA Special Session 1
Regulatory Filings
2011-08-14 English
Appendix 4C - quarterly 5 pages 182.2KB
Regulatory Filings
2011-07-31 English
Form 604 - Notice of change of interests of substantial hold 6 pages 71.3KB
Regulatory Filings
2011-07-31 English
FDA Clearance for Phase 3 Bone Marrow Transplant Trial 3 pages 244.9KB
Regulatory Filings
2011-07-06 English
Appendix 3B 8 pages 189.8KB
Regulatory Filings
2011-07-05 English
Amended Change of Director`s Interest Notice 2 pages 177.8KB
Regulatory Filings
2011-07-03 English
Change of Director`s Interest Notice 2 pages 101.8KB
Regulatory Filings
2011-06-30 English
FDA Clears Phase 2 Trial to Treat Degenerative Disc Disease 2 pages 156.2KB
Regulatory Filings
2011-06-28 English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 5 pages 124.9KB
Regulatory Filings
2011-06-21 English
Key Product Franchises Featured at Nomura Asia Equity Forum 18 pages 1.0MB
Regulatory Filings
2011-06-13 English
Revascor Increases Blood Supply to Damaged Heart Muscle 3 pages 269.9KB
Regulatory Filings
2011-06-08 English
MSB to Present at Goldman Sachs Global Healthcare Conference 1
Regulatory Filings
2011-06-05 English
Key USA Patents Increase Commercial Rights and Indications 2 pages 156.3KB
Regulatory Filings
2011-05-23 English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 5 pages 58.8KB
Regulatory Filings
2011-05-03 English
Appendix 4C - quarterly 5 pages 139.3KB
Regulatory Filings
2011-05-01 English
Mesoblast Included in S and P/ASX 200 Index 1 page
Regulatory Filings
2011-04-17 English
SandP to remove Tower Australia Group from SP/ASX Indices 1
Regulatory Filings
2011-04-17 English
Appendix 3B 7 pages 167.3KB
Regulatory Filings
2011-04-10 English
Mesoblast Update on Valeant Proposal to Cephalon 1
Regulatory Filings
2011-04-06 English
Mesoblast Statement on Valeant Proposal to Cephalon 1
Regulatory Filings
2011-03-30 English
Mesoblast CEO Named BioSpectrum Asia Person of the Year 2011 1
Regulatory Filings
2011-03-16 English
Appendix 3B 7 pages 169.2KB
Regulatory Filings
2011-03-10 English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 5 pages 58.8KB
Regulatory Filings
2011-03-09 English
Appendix 4D and Half Year Financial Report to 31 Dec 2010 30 pages 634.3KB
Regulatory Filings
2011-02-27 English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 5 pages 58.0KB
Regulatory Filings
2011-02-16 English
Change in substantial holding 5 pages 130.9KB
Regulatory Filings
2011-02-14 English
Mesoblast Issues New Equity to Cephalon, Increases Cash 2 pages 159.1KB
Regulatory Filings
2011-02-13 English
Cleansing Notice under Section 708A 1 page 136.4KB
Regulatory Filings
2011-02-13 English
Appendix 3B 8 pages 171.5KB
Regulatory Filings
2011-02-10 English
Section 708AA Notice - Cleansing Statement 2 pages 101.4KB
Regulatory Filings
2011-02-10 English
Mesoblast EGM Speech and Presentation 21 pages 864.6KB
Regulatory Filings
2011-02-08 English
Results of Meeting 2 pages 141.6KB
Regulatory Filings
2011-02-08 English
Appendix 4C - Strong Cash Position 6 pages 375.1KB
Regulatory Filings
2011-01-30 English
FORM 604 CHANGE OF INTERESTS OF SUB HOLDER 5 pages 57.9KB
Regulatory Filings
2011-01-12 English
Response to ASX Price Query 4 pages 197.1KB
Regulatory Filings
2011-01-12 English
Alliance Highlighted at JP Morgan Healthcare Conference 20 pages 1.4MB
Regulatory Filings
2011-01-11 English
Cardiac Events, Mortality and Hospitalization Reduced 3 pages 172.9KB
Regulatory Filings
2011-01-09 English
Notice of Extraordinary General Meeting/Proxy Form 14 pages 568.2KB
Regulatory Filings
2011-01-06 English